Oie M, Haugen I, Stubberud J, Oie M
Front Psychol. 2024; 15:1320986.
PMID: 38515967
PMC: 10955763.
DOI: 10.3389/fpsyg.2024.1320986.
Molina V, Fernandez-Linsenbarth I, Queipo-de-Llano M, Jimenez-Aparicio M, Vallecillo-Adame C, Aremy-Gonzaga A
Eur Arch Psychiatry Clin Neurosci. 2022; 273(6):1379-1386.
PMID: 36416961
PMC: 10449979.
DOI: 10.1007/s00406-022-01518-1.
Haugen I, Stubberud J, Haug E, McGurk S, Hovik K, Ueland T
BMC Psychiatry. 2022; 22(1):575.
PMID: 36031616
PMC: 9420179.
DOI: 10.1186/s12888-022-04197-3.
Pilling S, Clarke K, Parker G, James K, Landau S, Weaver T
Contemp Clin Trials. 2021; 113:106664.
PMID: 34958932
PMC: 8844585.
DOI: 10.1016/j.cct.2021.106664.
Haime Z, Watson A, Crellin N, Marston L, Joyce E, Moncrieff J
BMC Psychiatry. 2021; 21(1):597.
PMID: 34844572
PMC: 8628466.
DOI: 10.1186/s12888-021-03545-z.
Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.
Conn K, Burne T, Kesby J
Front Neurosci. 2020; 14:542.
PMID: 32655348
PMC: 7325949.
DOI: 10.3389/fnins.2020.00542.
Psychometrics and Validity of the Survey of Memory-Related Quality of Life in HIV Disease.
Sullivan K, Kulesz P, Woods S
Arch Clin Neuropsychol. 2019; 36(2):186-202.
PMID: 31732744
PMC: 7881976.
DOI: 10.1093/arclin/acz055.
The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity.
Kim S, Kim J, Shim J, Seo B, Jung S, Ryu J
Clin Psychopharmacol Neurosci. 2017; 15(3):261-268.
PMID: 28783936
PMC: 5565087.
DOI: 10.9758/cpn.2017.15.3.261.
Neuropsychological Impairment and Its Association with Violence Risk in Japanese Forensic Psychiatric Patients: A Case-Control Study.
Nishinaka H, Nakane J, Nagata T, Imai A, Kuroki N, Sakikawa N
PLoS One. 2016; 11(1):e0148354.
PMID: 26824701
PMC: 4732612.
DOI: 10.1371/journal.pone.0148354.
Neurobiology of cognitive remediation therapy for schizophrenia: a systematic review.
Thorsen A, Johansson K, Loberg E
Front Psychiatry. 2014; 5:103.
PMID: 25177300
PMC: 4133649.
DOI: 10.3389/fpsyt.2014.00103.
A history of health-related quality of life outcomes in psychiatry.
Revicki D, Kleinman L, Cella D
Dialogues Clin Neurosci. 2014; 16(2):127-35.
PMID: 25152652
PMC: 4140507.
Criminal victimisation in people with severe mental illness: a multi-site prevalence and incidence survey in the Netherlands.
Kamperman A, Henrichs J, Bogaerts S, Lesaffre E, Wierdsma A, Ghauharali R
PLoS One. 2014; 9(3):e91029.
PMID: 24609108
PMC: 3946683.
DOI: 10.1371/journal.pone.0091029.
Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies.
Rajji T, Miranda D, Mulsant B
Can J Psychiatry. 2014; 59(1):13-7.
PMID: 24444319
PMC: 4079219.
DOI: 10.1177/070674371405900104.
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review.
Henriksson R, Asklund T, Poulsen H
J Neurooncol. 2011; 104(3):639-46.
PMID: 21468776
PMC: 3170120.
DOI: 10.1007/s11060-011-0565-x.
The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.
Riedel M, Spellmann I, Schennach-Wolff R, Obermeier M, Musil R
Qual Life Res. 2010; 20(2):263-72.
PMID: 20922485
DOI: 10.1007/s11136-010-9744-z.
D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.
Shimazaki T, Kaku A, Chaki S
Psychopharmacology (Berl). 2010; 209(3):263-70.
PMID: 20198471
DOI: 10.1007/s00213-010-1794-y.
Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population.
Galehdari H, Pooryasin A, Foroughmand A, Daneshmand S, Saadat M
J Mol Neurosci. 2008; 38(2):178-81.
PMID: 18792810
DOI: 10.1007/s12031-008-9148-5.
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M
Eur Arch Psychiatry Clin Neurosci. 2007; 257(6):360-70.
PMID: 17629731
DOI: 10.1007/s00406-007-0739-x.
Psychomotor slowing in schizophrenia.
Morrens M, Hulstijn W, Sabbe B
Schizophr Bull. 2006; 33(4):1038-53.
PMID: 17093141
PMC: 2632327.
DOI: 10.1093/schbul/sbl051.